Current Clinical Trials

Opthea

Palmetto Retina - Wednesday, March 21, 2018

OPT 302-1002: A dose-ranging study of intravitreal OPT-302 in combination with Ranibizumab, compared with Ranibizumab alone, in participants with Neovascular Age-Related Macular Degeneration (wet AMD)

OPT 302-1003: Phase 1b/2a study of OPT-302 in combination with Aflibercept for persistent Central-Involved Diabetic Macular Edema

Trackback Link
http://www.palmettoretina.com/BlogRetrieve.aspx?BlogID=11185&PostID=753456&A=Trackback
Trackbacks
Post has no trackbacks.

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077